Based on its recent analysis of the pharmaceutical sourcing market, Frost & Sullivan recognizes Sciformix Corporation with the 2013 North America Entrepreneurial Knowledge Process Organization (KPO) Company of the Year Award. With deep subject-matter expertise in all phases of drug development, from initiation of clinical trials to post-marketing support, Sciformix is able to tailor a flexible solution to help its clients quickly and efficiently bring more drugs to the market and manage their product lifecycle in a compliant manner. Its client-focused and flexible business model spans a wide range of project needs, from niche client requests to end-to-end support. The Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic service development.
Each year, Frost & Sullivan presents this award to the company that has demonstrated entrepreneurial spirit by devising a strong growth strategy and robustly implementing it. The recipient has shown strength in terms of innovation in business processes, leadership in customer value as well as market penetration. In short, the award looks at the emerging market players in the industry and recognizes their best practices that are positioned for future growth excellence. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.
Sciformix continually enhances its in-house capabilities and expertise, and makes the most of it to offer integrated or stand-alone services in the areas of safety and risk management, clinical research and post-approval support, and regulatory affairs. Individual services in these areas include medical information support, case processing, aggregate report writing, safety surveillance and risk management, clinical operations support, statistics, programming, data management, writing of clinical/regulatory/medico-marketing documents and regulatory strategy. The company's ability to attract best-in-class talent and develop differentiated services that fill the existing gaps left by its competitors - who may focus on operations but not science, or science but not processes, or larger multi-industry organizations that lack the advantage of specialized life science expertise - enables it to help clients manage the escalating costs of drug development while maintaining high quality standards.
The company's strategy to pace its growth to ensure sustainable delivery of quality services has served it well. Testifying to the soundness of its business model, Sciformix had in place all essential organizational infrastructure, such as an effective performance management system and standard operating procedures, within the first year of operations. Since inception, the company's technology infrastructure, processes and people have been a solid foundation to support its aggressive, yet robust growth. Fueling this strategy is Sciformix's culture of fostering innovation and scientific excellence.
"Sciformix continues to focus on service innovation while continually adding value from a cost and technology perspective. An example is the company's investment in a safety database has allowed it to cater to the needs of large to mid-size life science companies that do not desire to invest heavily on in-house resources," said Frost & Sullivan Senior Industry Analyst Deborah Toscano. In addition to technology foresight, the company's deep expertise in life science process optimization positions Sciformix as a niche partner in their industry. "To meet clients' needs, Sciformix has implemented the application of LEAN methodology to its core processes, resulting in enhanced efficiencies, productivity and quality".
Sciformix has used its ability to anticipate future needs to focus on specialized, differentiated services with a flexible approach tailored to clients' specific needs. Unsurprisingly, it has a large percentage of repeat business and has managed to retain all of its initial clients. Its business locations in the United States, India and the Philippines allow it to offer cost-effective solutions while maintaining global coverage.
About Sciformix Corporation
Sciformix Corporation (sciformix.com) is a world-leading Knowledge Process Organization (KPO), providing scientific knowledge-based services to biopharmaceutical, generics, consumer products, medical devices and other healthcare companies with the ultimate objective of improving quality of healthcare for patients worldwide. With our expertise in Safety and Risk Management, Clinical Research & Post-Approval Services and Regulatory Affairs, we partner with global life science companies to provide high-quality scientific knowledge-based services that deliver better-quality outcomes and improved efficiencies across the entire product lifecycle. Sciformix's corporate headquarters is located in Westborough, Mass., with operations in USA, India and the Philippines.
Sciformix is dedicated to providing our clients outstanding services and solutions, fueled by an unrivalled commitment to quality. We share the same level of involvement and passion as our clients by becoming an integral part of their team. Our distinct combination of scientific expertise, process rigor and technology innovation delivers consistent, reliable and insightful results. Our ability to scale and grow with our clients' evolving needs means we are flexible and focused to their success in delivering safe products with more efficiency and greater speed. We help them make the right decisions at the right time by providing Trusted Services Built on Science.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation.
Contact: Susan Najjar
P: 617.264.0339 - E: E: susan.najjar[.]sciformix.com.